Berardo Sarubbi is an expert in Cardiology at Ospedale Monaldi (Italy). As of October 2026, ScienceLeadR ranks Berardo Sarubbi in the top 1% of experts worldwide for Cardiovascular Abnormalities, Congenital Abnormalities and Heart Defects, Congenital. Berardo Sarubbi has authored 322 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 2 of them ongoing. SLR score: 983 (community average: 125). How the SLR is computed.

LeadR Profile

Berardo Sarubbi Ospedale Monaldi Italy
983 ScienceLeadR Reputation 983
Network Map

Cardiology

Subspecialties: Pediatrics - Public Health - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

Parthenope University of Naples

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 322

Citations

Citations: 4 158 1st author: 43 Last author: 76 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Single-chamber retrievable leadless pacemaker in adult congenital heart disease: A single-center experience.
PMID 42936582 — heart defects, congenital, heart diseases, heart
Heart Rhythm O220260
Fontan Failure: Current State of the Art in Mechanical Circulatory Support and Transplantation.
PMID 42794236 — heart defects, congenital, heart diseases, heart, heart transplantation, therapeutics, transplantation, mechanical circulatory support
Children (Basel)20260
Single Ventricle Fontan: The Basics for General Cardiologists.
PMID 42403550 — physiology, cardiovascular diseases, cardiologists
Methodist Debakey Cardiovasc J20260
Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).
PMID 42391650 — congenitally corrected transposition of the great arteries, hypertension, hypertension, pulmonary, capillaries, arteries, arterial switch operation, hemodynamics
JACC Adv20260
Intermittent Levosimendan Administration for Advanced Heart Failure Treatment in Adults with Congenital Heart Disease (Levo-ACHD Study).
PMID 42356182 — heart defects, congenital, sample size, heart diseases, hospitalization, heart failure, heart, treatment failure, drug-related side effects and adverse reactions, transplants, therapeutics
Medicina (Kaunas)20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2

By status:

Recruiting 2

By type:

Observational 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
BRING UP 3 Heart Failure
NCT06279988 — heart failure, heart, heart failure, systolic, therapeutics
N/ARecruiting2023
BRING UP Prevention
NCT06275113 — myocardial ischemia, heart diseases, coronary artery disease, heart, arteries, vascular diseases, cerebrovascular disorders, peripheral vascular diseases, peripheral arterial disease, ischemia
N/ARecruiting2023

LeadR Networks

Main global connection map